波多野结衣办公室双飞_制服 丝袜 综合 日韩 欧美_网站永久看片免费_欧美一级片在线免费观看_免费视频91蜜桃_精产国品一区二区三区_97超碰免费在线观看_欧美做受喷浆在线观看_国产熟妇搡bbbb搡bbbb_麻豆精品国产传媒

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Editorials

Pharmaceutical levies won't prompt reshoring: China Daily editorial

chinadaily.com.cn | Updated: 2025-08-06 20:49
Share
Share - WeChat
This photo taken on Sept 28, 2023 shows the US Capitol building in Washington, DC, the United States. [Photo/Xinhua]

After imposing sweeping "reciprocal tariffs" against the world four months ago, the United States is mulling a new round of targeted sector-specific tariff attacks.

US President Donald Trump said on Tuesday that he plans to announce tariffs on semiconductors and chips in the "next week or so", and place a "small tariff" on pharmaceutical imports before hiking it to 150 percent within 18 months and eventually to 250 percent.

Although he did not specify the initial tariff rate on pharmaceuticals, Trump said in February that sectoral tariffs on pharmaceuticals and semiconductor chips would start at "25 percent or higher", rising substantially over the course of a year.

The US initiated a Section 232 investigation on pharmaceutical products in April, purportedly to verify the impact of imports on "national security". It is believed this was a prelude to the planned levies which the US leader hopes can help the US boost the domestic production of medicines.

Pharmaceutical drug production in the US has shrunk dramatically over the last few decades. In 2024, the US' trade deficit in medicines reached $139 billion out of a total goods trade deficit of $1.2 trillion. Many US pharmaceutical companies have moved their manufacturing operations to other countries, such as Ireland, due to lower labor costs and other factors. Although they seem to be contributors to the US' trade deficit, they are the major beneficiaries of the model.

But industry observers have warned that the planned tariffs, along with an executive order of the president in May, could drive up costs, deter investments in the US, affect the whole industry's research and development, and disrupt the drug supply chains, putting patients at risk. The executive order aims to slash drug costs by tying the prices of some medicines in the US to lower ones abroad.

In response to the possible resistance from pharmaceutical companies and the wide concerns about rising medical bills for US families, the US president last week sent letters to 17 drugmakers calling on them to commit to steps to lower US drug prices by Sept 29. That includes agreeing to provide their full portfolio of existing medicines at the lowest price offered in other developed nations to every single medicaid patient, among other steps. The information they are pressed to provide is expected to be used to facilitate the implementation of the aforementioned "most favored nation" policy. The US drugmakers are obviously being caught in a similar dilemma to that of US carmakers when the US raised tariffs on imported vehicles and parts.

Yet the US administration's maximum pressure tactics are already producing results. Companies such as Eli Lilly and Johnson & Johnson announced fresh US investments in the past few months, according to a CNBC report. And Reuters has reported that AstraZeneca has just committed $50 billion to expand its operations in the US.

Although the US administration seems to be leaving the companies enough time to relocate their production to the US with its planned phased tariff hikes over more than a year, to what extent the latter will comply depends on their profit-cost balance. The exorbitant 250 percent tariffs the US leader threatened, the highest for a sector so far, to some extent reflects the huge cost it will incur to shape a US-led pharmaceutical industry by reforging supply chains around the world.

The pharmaceutical industry boasts arguably one of the most sophisticated systems of global division of labor. The planned tariffs, if they materialize, will also slow down the catch-up of developing countries in the industry by realizing the US' control of their product sources and related technologies and equipment. That will certainly prompt some emerging market economies to accelerate independent innovation in the industry.

The proposed tariffs also look set to further complicate the already strained trade relations between the US and Europe. Ireland, Germany and Switzerland, which are the top three exporters of pharmaceuticals to the US, accounting for about 60 percent of the exports to the country combined, will bear the main brunt of the levies.

Just like in the chip and artificial intelligence sectors, the formation of two de facto parallel systems in the pharmaceutical sector will markedly increase R&D costs and slow the pace of technological development. Ultimately, it is ordinary people who will pay the price for the tariff hikes.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
波多野结衣办公室双飞_制服 丝袜 综合 日韩 欧美_网站永久看片免费_欧美一级片在线免费观看_免费视频91蜜桃_精产国品一区二区三区_97超碰免费在线观看_欧美做受喷浆在线观看_国产熟妇搡bbbb搡bbbb_麻豆精品国产传媒
800av在线播放| 国产女人aaa级久久久级| 一区二区三区在线视频免费| 成人黄色免费短视频| 免费精品在线视频| 国产精品美女久久久久久久久| 激情图片小说一区| 四季av中文字幕| 国产亚洲福利社区一区| 国产麻豆欧美日韩一区| 亚洲欧美日韩第一页| 国产农村妇女精品| 成人综合婷婷国产精品久久| 我要看黄色一级片| 国产精品不卡在线| 99国产欧美另类久久久精品| 色94色欧美sute亚洲线路一久 | 国产精品三级av| 国产99久久久精品| 日本黄色录像视频| 亚洲欧洲色图综合| 9i在线看片成人免费| 欧洲国内综合视频| 亚洲1区2区3区视频| 欧美高清性xxxx| 久久综合九色综合欧美亚洲| 国产精品99精品久久免费| 国语对白在线播放| 一区二区日韩av| 国产极品一区二区| 精品精品国产高清a毛片牛牛 | 亚洲熟女少妇一区二区| 中文字幕第一区| 91免费国产在线| 欧美一区二区三区在线看| 久久99久久久久| 中国毛片直接看| 亚洲一区二区精品3399| 精品无码在线视频| 国产欧美日韩不卡免费| 99精品欧美一区| 日韩一区二区三| 国产福利视频一区二区三区| 91黄色免费看| 日本v片在线高清不卡在线观看| 91麻豆制片厂| 亚洲综合在线观看视频| 加勒比综合在线| 中文字幕日韩一区| 精品国产av色一区二区深夜久久| xf在线a精品一区二区视频网站| 国产999精品久久| 欧美日韩精品专区| 中文字幕一区在线观看| 岛国精品一区二区三区| 天天综合色天天综合色h| 国产精品久久久久久久av| 中文字幕制服丝袜一区二区三区| 亚洲乱妇老熟女爽到高潮的片 | 久久精品亚洲麻豆av一区二区| 国产91精品露脸国语对白| 欧美日韩视频在线第一区 | 777色狠狠一区二区三区| 久久99国产精品久久| 一本大道av伊人久久综合| 日韩av一区二区三区四区| 久久精品黄色片| 日本va欧美va精品| 91久久精品网| 精品一区二区三区视频在线观看 | 国产成人鲁色资源国产91色综 | 中文幕无线码中文字蜜桃| 日韩一区中文字幕| 国产精品扒开腿做爽爽| 亚洲激情一二三区| 国产综合精品久久久久成人av| 亚洲一区在线观看免费| 国产又黄又粗又猛又爽的| 亚洲成人在线观看视频| 欧美日韩午夜视频| 伦理电影国产精品| 欧美日韩国产精选| 成人免费黄色大片| 2014亚洲片线观看视频免费| 日韩精品――色哟哟| 亚洲国产精品成人久久综合一区| 搡老熟女老女人一区二区| 亚洲日本欧美天堂| ass极品国模人体欣赏| 天天综合日日夜夜精品| 91九色02白丝porn| 粉嫩蜜臀av国产精品网站| 精品久久久久av影院| 手机免费看av片| 亚洲精选免费视频| 婷婷伊人五月天| 国产一区二区免费看| 日韩精品一区二区三区四区| 性色av浪潮av| 亚洲欧洲成人精品av97| 国产免费嫩草影院| 精品一区二区三区影院在线午夜| 欧美一区三区二区| 李丽珍裸体午夜理伦片| 一区二区三区精品在线观看| 亚洲av无码一区二区三区在线| 国产在线看一区| 26uuu成人网一区二区三区| 国产人妻人伦精品1国产丝袜| 亚洲永久免费av| 欧美在线视频全部完| 波波电影院一区二区三区| 国产精品素人视频| 亚洲一区电影在线观看| 国产一区二区美女| 国产日韩精品一区二区三区 | 91成人破解版| 日本欧美在线观看| 欧美一区二区啪啪| 国产精品300页| 日韩高清欧美激情| 欧美一二三在线| 欧美做受喷浆在线观看| 日韩高清在线不卡| 日韩亚洲欧美高清| 中文字幕一二三四区| 老司机午夜精品| 久久婷婷一区二区三区| 中文字幕免费在线看线人动作大片| 麻豆中文一区二区| 久久婷婷国产综合国色天香| 亚洲天堂岛国片| 国产黄色精品网站| 国产精品久久毛片| 91精品办公室少妇高潮对白| 国产黄色一区二区三区| 亚洲国产另类av| 日韩一区二区三区视频在线| 亚洲熟妇无码av| 激情深爱一区二区| 国产精品三级视频| 91黄色小视频| 久久久久亚洲无码| 久久精品理论片| 中文在线一区二区| 一区二区在线观看免费视频| 99re这里只有精品首页| 亚洲成人7777| 精品理论电影在线| 国精产品视频一二二区| www.成人在线| 亚洲成人资源在线| 亚洲精品一区二区三区精华液| 永久免费未视频| 欧美熟妇另类久久久久久多毛| 污片在线观看一区二区| 精品电影一区二区| 动漫性做爰视频| 又色又爽又黄18网站| 麻豆精品新av中文字幕| 中文字幕国产精品一区二区| 欧美在线视频日韩| 男人操女人动态图| 成人精品免费网站| 婷婷成人激情在线网| 久久精品欧美日韩| 欧洲精品一区二区| 色欲av无码一区二区三区| 国产99精品视频| 亚洲电影欧美电影有声小说| 久久伊人中文字幕| 我和岳m愉情xxxⅹ视频| 国产电影一区二区三区| 亚洲一区影音先锋| 国产亚洲欧美在线| 欧美日韩在线直播| 91精品久久久久久久久久久久| av资源网一区| 免费高清视频精品| 国产精品久久久久影院| 7777精品伊人久久久大香线蕉的 | 国产美女永久免费无遮挡| 成人高清免费观看| 日韩不卡一二三区| 综合在线观看色| 日韩欧美中文字幕制服| 色综合天天视频在线观看| 无码人妻aⅴ一区二区三区| 成人中文字幕合集| 日韩精品一二三区| 亚洲欧美日韩国产手机在线| 日韩欧美的一区| 一本色道久久综合亚洲aⅴ蜜桃| jlzzjizz在线播放观看| 成人精品在线视频观看| 蜜桃传媒麻豆第一区在线观看| 亚洲免费观看高清在线观看| 久久亚洲综合av| 欧美丰满少妇xxxbbb| √天堂中文官网8在线|